$Eton Pharmaceutical (ETON.US)$
$ETON Did anyone really think that Biorphen®, Rezipres®, and Cysteine Hydrochloride all of which are for indications that are not for rare diseases were long term holdings for a rare disease company?
Like they said in their CC, they are now focusing all their $$ into researching and developing therapies for RARE diseases with unmet need They have spent the entire 1H of 2022 establishing a relationship specialist in pediatric endocrinology...